SlideShare a Scribd company logo
1 of 27
Under the Guidance of:
Er. Brajendra Shukla
Coordinator, Biotechnology
Engineering
I.E.T., Bundelkhand University, Jhansi
Dr. Anand Kr. Pandey
Lecturer (Biotechnology Engineering)
I.E.T., Bundelkhand University, Jhansi
Presented By:
Archana Kushwaha
B.Tech (Biotechnology) 2nd Year
Rafat Sabir
B.Tech (Biotechnology) 2nd Year
Swati Tripathi
B.Tech (Biotechnology) 1st Year
 A PATHOGENIC MICROORGANISM AND ESPECIALLY
A BACTERIUM THAT HAS DEVELOPED RESISTANCE
TO THE MEDICATIONS NORMALLY USED AGAINST
IT.
 IF A BACTERIUM CARRIES SEVERAL ANTIBIOTIC
RESISTANCE GENES IT IS CALLED MULTIRESISTANT
OR INFORMALLY A SUPERBUG OR SUPER
BACTERIA.
 THE BRANCH OF SCIENCE WHICH DEALS WITH THE
STUDY OF SUPERBUGS IS CALLED METAGENOMICS.
1. Uncontrolled, improper and indiscriminate use of
antibiotics for therapy and prophylaxis.
2. Inadequate lengths of therapy.
3. Unnecessary use, lack of activity, insufficient doses.
4. Poor hand hygiene & failure of infection control
measures.
5. Pollution from nanomaterial, heavy metal, sewage
sludge, animal slurry, disinfectants and fabric
softeners.
0
2
4
6
8
10
12
14
16
18Numberofagentsapproved
0
1983-87 1988-92 1993-97 1998-02 2003-05 2008
Resistance
•Infectious Diseases Society of America. Bad Bugs, No Drugs. July 2004; Spellberg B et al. Clin Infect Dis. 2004;38:1279-1286;
•New antimicrobial agents. Antimicrob Agents Chemother. 2006;50:1912
Bars represent number of new antimicrobial agents approved by the FDA during that period
Mechanism of Antibiotic
Resistance
 Drug inactivation or modification.
 Alteration of target site.
 Reduced drug accumulation.
 Horizontal gene transfer and
unlinked point mutations in the
pathogen genome.
 Innate genetic mutation.
 Accepting resistance genes
from other bacteria.
 Conjugation, Transformation
and Transduction.
 Introduced artificially into a
microorganism through
laboratory protocols,
sometimes used as a
 By enzyme inactivation.
Infectious Disease
Society of America
Examples of SUPERBUGS:
1. MRSA (Methicillin Resistant Staphylococcus aureus)
2. H1N1 (Hemagglutinin Type 1 and Neuraminidase
Type 1)
3. NDM-1 (New Delhi Metallo β Lactamase-1)
4. VRSA (Vancomycin Resistant Staphylococcus aureus)
5. ESBL (Extended Spectrum Beta-Lactamase)
6. VRE (Vancomycin Resistant Enterococcus)
7. MRAB (Multidrug Resistant Actinomucor baumannii ).
FEWBAD BUGS, FEW DRUGS
 Resistant against antibiotic
Methicillin.
 Found on the mucous membranes
and the human skin. This is one
virus that does not need open
wound to enter just contact with
your skin.
 It was one of the earlier bacteria in
which penicillin resistance was
1. MRSA: Methicillin Resistant Staphylococcus aureus
MRSA
2. H1N1 Flu Virus (Swine Flu)
 H1N1 virus responsible for today’s biggest
threat i.e. Swine Flu is also becoming antiviral
resistant.
 A class of antivirals, ‘neuraminidase inhibitors
(NAIs)’ is effective against all human influenza
viruses.
e.g. oseltamivir & zanamivir.
 Doctors generally prescribes these antivirals
against swine flu.
 Studies done by MEDLINE & EMBASE revealed
a pooled incidence rate for oseltamivir
resistance of 2.6% as a result of oseltamivir
use.
MORBIDITY AND MORTALITY
CDC estimates that the number of MRSA has doubled
nationwide 1999 approx. 127,000 up to 2005 approx.
278,000.
At the same time the amount of deaths increased from
11,000 to more than 17,000.
Incidence increase in β-Lactamase from 17% to 23% between
1991 and 2001 in UK.
44 isolates with NDM-1 in Chennai, 26 in Haryana, 37 in the
UK, and 73 in other sites in India and Pakistan.
Death attributable to AMR (Anti Microbial
Resistance) every year compared to other
causes of death.
Source: Wikipedia by Jim O'Neill Chairman of the Review on Antimicrobial Resistance
 Selecting the most appropriate antibiotic
based on the patient, risk factors,
suspected infection and resistance.
 Administering antibiotics at the right
dose, duration & take them only if
necessary.
 Completing the full prescription given by
doctor, even if you feel better.
 Changing antibiotic dosage or therapy
based on resistance.
 Replace conventional antibiotics to
peptide antibiotics.
WASH YOUR HANDS!!! And
maintain a hygienic surrounding.
BSI gloves, mask with face shield,
gown-Not a bad idea.
Disinfect you and your equipment
including your truck.
Be environment friendly and say
‘NO’ to pollution.
NANOTECHNOLOGY BOOST WAR ON
SUPERBUGS
 Scientists from the London Centre for
Nanotechnology (LCN) are using a novel
nanomechanical approach to investigate the
workings of vancomycin.
 Cantilever Array coated with mucopeptide –
Leads to the development of more powerful
and effective antibiotics in future.
 Engineers design nanoparticles that deliver
high doses of antibiotics directly to bacteria.
Cantilever Array
Nanoparticles(green) targeting Bacteria(red)
1. Gene-editing Systems
(i). CRISPR (Clustered Regularly Interspaced Short
Palindromic Repeats)
 MIT engineers have developed a gene-editing system-CRISPR that can kill
superbug.
 It involves a set of proteins , used by bacteria against bacteriophages. One
of these proteins is Cas9, a DNA cutting enzyme.
 RNA guide strands of bacteria are used to target genes for antibiotic
resistance like NDM-1 & SVH-18.
 Studies have done on waxworm & mice.
Biotechnological Approach in Prevention
of
‘SUPERBUGS’
(ii) TALENs (Transcription Activator Like Effector Nucleases)
 TALEs are naturally occurring protein from the pathogen
Xanthomonas containing DNA binding domains.
 Can be used to edit genomes using double strand breaks & it cleaves at
desired site.
 Use to generate mutant alleles of 15 genes in cultured somatic cells or
human pluripotent stem cells.
 Use to generate stably modified human embryonic stem cell &
induced pluripotent stem cells (IPSCs) to generate knockout mice,
knockout zebrafish.
 Utilized experimentally to correct genetic errors underlying diseases.
2. Combi-GEM (Combinatorial Genetics En Masse)
 Enables the rapid generation of high-order barcoded
combinations of genetic elements.
 Researchers created a library of 34,000 pairs of
bacterial genes which code for transcription factor.
 These genes are then transmitted into superbugs &
treated them with different antibiotic.
 Illumina sequencing reveals those gene pairs that
potentiated the killing of bacteria by manifolds.
 Once the mechanism is investigated, we can design
more effective antibiotics.
3. Engineered Viruses (Bacteriophages)
 Researchers have engineered a virus that
eliminates bacterial defense system and
hence increase the effectiveness of
antibiotics.
 These viruses attack the SOS system of
bacteria- A DNA repair system that comes
into action when bacteria is exposed to
antibiotics.
 Used in conjunction with traditional
antibiotics (Quonolones, β-lactams).
4. Beneficial Insects
Scientists also hypothesised that
locust brain juice could cut MRSA
in humans because it contains
substances that kill bacteria.
Honey is also studied as a weapon
against superbug.
5. Computer Aided Drug Designing (CAD)
 Virtual screening of billions of compounds.
 Availability of chemical databases & their
online distribution is useful in drug designing.
 Many softwares are available for screening the
lead like compound from chemical databases.
 X-Ray, NMR and Docking are milestones in
structure based drug designing.
 Are cost-effective, reliable and time-saving.
6. FIRST WEAPON AGAINST MRSA
 The drug, Staphefekt, is reported as the
first weapon against MRSA infection.
 It combines two bits of a enzyme-
‘Endolysin’, found in viruses.
 It latches on to bacterium’s outer skin
part.
 It specifically kill Staphylococcus and
doesn’t harm other bacteria.
MRSA
 Research is being done to find treatment.
 A newly discovered antibiotic, called
‘Teixobactin’, kills a wide range of superbugs.
 “eCAPs” (engineered Cationic Antimicrobial
Peptides) are being synthesised.
 Newer Antibiotics in pipeline:- Dalbavancin,
Oritavancin, Telavancin, Ceftobiprole
(Zeftera®), Ceftaroline, Faropenem.
eCAPs
References:
 Textbook on Microbiology by Michael J.Paleczar, JR.,
E.C.S.Chan, Noel R.Kreig.
 Textbook on Biochemistry by Lehninger.
 en.wikipedia.org
 www.nanowork.com
 www.sciencedaily.com
 www.latimes.com
 www.pubmed.com
 www.nature.com
YOUR
QUERIES..???

More Related Content

What's hot

Phage Therapy against mutildrug-resistant Pseudomonas aeruginosa using a muri...
Phage Therapy against mutildrug-resistant Pseudomonas aeruginosa using a muri...Phage Therapy against mutildrug-resistant Pseudomonas aeruginosa using a muri...
Phage Therapy against mutildrug-resistant Pseudomonas aeruginosa using a muri...ILRI
 
Sigma Xi Powerpoint Presentation
Sigma Xi Powerpoint PresentationSigma Xi Powerpoint Presentation
Sigma Xi Powerpoint PresentationDiana Demchenko
 
Phage therapy
Phage therapyPhage therapy
Phage therapyaprnasab
 
A n ti H I V Using Nanorobots
A n ti H I V Using NanorobotsA n ti H I V Using Nanorobots
A n ti H I V Using NanorobotsIOSR Journals
 
Application of Bacteriophage Endolysin plyGRCS as an Antimicrobial
Application of Bacteriophage Endolysin plyGRCS as an AntimicrobialApplication of Bacteriophage Endolysin plyGRCS as an Antimicrobial
Application of Bacteriophage Endolysin plyGRCS as an AntimicrobialShannon Jin
 
The environmental dimensions of antibiotic resistance
The environmental dimensions of antibiotic resistanceThe environmental dimensions of antibiotic resistance
The environmental dimensions of antibiotic resistanceSIANI
 
Vaccine Designing
Vaccine DesigningVaccine Designing
Vaccine DesigningMiccrophage
 
GENATICS OF IMMUNITY
GENATICS OF IMMUNITYGENATICS OF IMMUNITY
GENATICS OF IMMUNITYMo Mirghani
 
Jamboree final presentation!
Jamboree final presentation!Jamboree final presentation!
Jamboree final presentation!Waterloo iGEM
 
Applications of medical biotechnology
Applications of medical biotechnologyApplications of medical biotechnology
Applications of medical biotechnologyAiswarya Babu N
 
Peace seminar 2222
Peace seminar 2222Peace seminar 2222
Peace seminar 2222Elvis Ogbe
 
Rappuoli slide scienza e industria 27:11:2013rid
Rappuoli slide scienza e industria 27:11:2013ridRappuoli slide scienza e industria 27:11:2013rid
Rappuoli slide scienza e industria 27:11:2013ridScienzainrete
 
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...kamal shrestha
 

What's hot (20)

Phage therapy
Phage therapyPhage therapy
Phage therapy
 
Phage Therapy against mutildrug-resistant Pseudomonas aeruginosa using a muri...
Phage Therapy against mutildrug-resistant Pseudomonas aeruginosa using a muri...Phage Therapy against mutildrug-resistant Pseudomonas aeruginosa using a muri...
Phage Therapy against mutildrug-resistant Pseudomonas aeruginosa using a muri...
 
PHAGE THERAPY-NEW
PHAGE THERAPY-NEWPHAGE THERAPY-NEW
PHAGE THERAPY-NEW
 
Sigma Xi Powerpoint Presentation
Sigma Xi Powerpoint PresentationSigma Xi Powerpoint Presentation
Sigma Xi Powerpoint Presentation
 
Phage therapy
Phage therapyPhage therapy
Phage therapy
 
Phage therapy
Phage therapyPhage therapy
Phage therapy
 
A n ti H I V Using Nanorobots
A n ti H I V Using NanorobotsA n ti H I V Using Nanorobots
A n ti H I V Using Nanorobots
 
Phage therapy
Phage therapyPhage therapy
Phage therapy
 
Vaccine 5 march
Vaccine 5 march Vaccine 5 march
Vaccine 5 march
 
Application of Bacteriophage Endolysin plyGRCS as an Antimicrobial
Application of Bacteriophage Endolysin plyGRCS as an AntimicrobialApplication of Bacteriophage Endolysin plyGRCS as an Antimicrobial
Application of Bacteriophage Endolysin plyGRCS as an Antimicrobial
 
The environmental dimensions of antibiotic resistance
The environmental dimensions of antibiotic resistanceThe environmental dimensions of antibiotic resistance
The environmental dimensions of antibiotic resistance
 
Vaccine Designing
Vaccine DesigningVaccine Designing
Vaccine Designing
 
GENATICS OF IMMUNITY
GENATICS OF IMMUNITYGENATICS OF IMMUNITY
GENATICS OF IMMUNITY
 
Jamboree final presentation!
Jamboree final presentation!Jamboree final presentation!
Jamboree final presentation!
 
Applications of medical biotechnology
Applications of medical biotechnologyApplications of medical biotechnology
Applications of medical biotechnology
 
Vaccine types
Vaccine typesVaccine types
Vaccine types
 
Peace seminar 2222
Peace seminar 2222Peace seminar 2222
Peace seminar 2222
 
Rappuoli slide scienza e industria 27:11:2013rid
Rappuoli slide scienza e industria 27:11:2013ridRappuoli slide scienza e industria 27:11:2013rid
Rappuoli slide scienza e industria 27:11:2013rid
 
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
 
New era antimicrobials
New era antimicrobialsNew era antimicrobials
New era antimicrobials
 

Viewers also liked

Superbugs Prevention And Treatment Pp
Superbugs Prevention And Treatment PpSuperbugs Prevention And Treatment Pp
Superbugs Prevention And Treatment Ppguest73582c
 
Anti Microbial Resistance (AMR)
Anti Microbial Resistance (AMR)Anti Microbial Resistance (AMR)
Anti Microbial Resistance (AMR)Dr. Manu Chaudhary
 
Superbug selection and associated clinical and non clinical
Superbug selection and associated clinical and non clinicalSuperbug selection and associated clinical and non clinical
Superbug selection and associated clinical and non clinicalKarthik Kumaragurubaran
 
Results RNA ACS 200 - Antibiotic Resistant Superbugs
Results RNA ACS 200 - Antibiotic Resistant SuperbugsResults RNA ACS 200 - Antibiotic Resistant Superbugs
Results RNA ACS 200 - Antibiotic Resistant SuperbugsResults RNA
 
R. Villano - Superbugs & superdrugs p.te 6: new therapeutic coumpounds
R. Villano - Superbugs & superdrugs p.te 6: new therapeutic coumpoundsR. Villano - Superbugs & superdrugs p.te 6: new therapeutic coumpounds
R. Villano - Superbugs & superdrugs p.te 6: new therapeutic coumpoundsRaimondo Villano
 
Evolution of superbug
Evolution of superbugEvolution of superbug
Evolution of superbugPrajith V
 
Superbugs and the role of diagnostics explained
Superbugs and the role of diagnostics explainedSuperbugs and the role of diagnostics explained
Superbugs and the role of diagnostics explainedMedTech Europe
 
Superbugs-Mechanisms, Control & Utilization
Superbugs-Mechanisms, Control & UtilizationSuperbugs-Mechanisms, Control & Utilization
Superbugs-Mechanisms, Control & UtilizationNoor Ain
 
[Challenge:Future] Fighting with Superbugs
[Challenge:Future] Fighting with Superbugs[Challenge:Future] Fighting with Superbugs
[Challenge:Future] Fighting with SuperbugsChallenge:Future
 
ESBL: From petri dish to patient
ESBL: From petri dish to patientESBL: From petri dish to patient
ESBL: From petri dish to patientPathKind Labs
 
The Superbug MRSA !!
The Superbug MRSA !!The Superbug MRSA !!
The Superbug MRSA !!Aruna M Das
 
Superbugs and Bundles of Care
Superbugs and Bundles of CareSuperbugs and Bundles of Care
Superbugs and Bundles of CareGhie Santos
 

Viewers also liked (19)

Superbug
SuperbugSuperbug
Superbug
 
Superbugs Prevention And Treatment Pp
Superbugs Prevention And Treatment PpSuperbugs Prevention And Treatment Pp
Superbugs Prevention And Treatment Pp
 
Superbug
SuperbugSuperbug
Superbug
 
Anti Microbial Resistance (AMR)
Anti Microbial Resistance (AMR)Anti Microbial Resistance (AMR)
Anti Microbial Resistance (AMR)
 
Superbug selection and associated clinical and non clinical
Superbug selection and associated clinical and non clinicalSuperbug selection and associated clinical and non clinical
Superbug selection and associated clinical and non clinical
 
Results RNA ACS 200 - Antibiotic Resistant Superbugs
Results RNA ACS 200 - Antibiotic Resistant SuperbugsResults RNA ACS 200 - Antibiotic Resistant Superbugs
Results RNA ACS 200 - Antibiotic Resistant Superbugs
 
R. Villano - Superbugs & superdrugs p.te 6: new therapeutic coumpounds
R. Villano - Superbugs & superdrugs p.te 6: new therapeutic coumpoundsR. Villano - Superbugs & superdrugs p.te 6: new therapeutic coumpounds
R. Villano - Superbugs & superdrugs p.te 6: new therapeutic coumpounds
 
Evolution of superbug
Evolution of superbugEvolution of superbug
Evolution of superbug
 
Superbugs and the role of diagnostics explained
Superbugs and the role of diagnostics explainedSuperbugs and the role of diagnostics explained
Superbugs and the role of diagnostics explained
 
Mrsa 2009
Mrsa 2009Mrsa 2009
Mrsa 2009
 
Superbugs-Mechanisms, Control & Utilization
Superbugs-Mechanisms, Control & UtilizationSuperbugs-Mechanisms, Control & Utilization
Superbugs-Mechanisms, Control & Utilization
 
Superbug
SuperbugSuperbug
Superbug
 
[Challenge:Future] Fighting with Superbugs
[Challenge:Future] Fighting with Superbugs[Challenge:Future] Fighting with Superbugs
[Challenge:Future] Fighting with Superbugs
 
ESBL: From petri dish to patient
ESBL: From petri dish to patientESBL: From petri dish to patient
ESBL: From petri dish to patient
 
The Superbug MRSA !!
The Superbug MRSA !!The Superbug MRSA !!
The Superbug MRSA !!
 
Superbugs
Superbugs Superbugs
Superbugs
 
Superbugs and Bundles of Care
Superbugs and Bundles of CareSuperbugs and Bundles of Care
Superbugs and Bundles of Care
 
AUPDATE
AUPDATEAUPDATE
AUPDATE
 
Mrsa ppt
Mrsa pptMrsa ppt
Mrsa ppt
 

Similar to Final Presentation

Top 15 Biopharma Research Trends to Watch in 2023.pdf
Top 15 Biopharma Research Trends to Watch in 2023.pdfTop 15 Biopharma Research Trends to Watch in 2023.pdf
Top 15 Biopharma Research Trends to Watch in 2023.pdfThe Lifesciences Magazine
 
Environmental Transmission of Antimicrobial Resistance
Environmental Transmission of Antimicrobial ResistanceEnvironmental Transmission of Antimicrobial Resistance
Environmental Transmission of Antimicrobial ResistancePranab Chatterjee
 
The Significance of Lifescience- An In-depth Exploration.pdf
The Significance of Lifescience- An In-depth Exploration.pdfThe Significance of Lifescience- An In-depth Exploration.pdf
The Significance of Lifescience- An In-depth Exploration.pdfhealthcare360social
 
AMR & Alternative Stratergies - Microbiology
AMR & Alternative Stratergies - MicrobiologyAMR & Alternative Stratergies - Microbiology
AMR & Alternative Stratergies - MicrobiologySijo A
 
Science Magazine_Moderna_2017
Science Magazine_Moderna_2017Science Magazine_Moderna_2017
Science Magazine_Moderna_2017Marianne Eybye
 
mRNA vaccines against emerging infectious diseases; A challenging approach of...
mRNA vaccines against emerging infectious diseases; A challenging approach of...mRNA vaccines against emerging infectious diseases; A challenging approach of...
mRNA vaccines against emerging infectious diseases; A challenging approach of...AI Publications
 
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...Premier Publishers
 
broad spectrum antibiotics - Dr Sanjana Ravindra
broad spectrum antibiotics - Dr Sanjana Ravindrabroad spectrum antibiotics - Dr Sanjana Ravindra
broad spectrum antibiotics - Dr Sanjana RavindraDr. Sanjana Ravindra
 
Bioinformatics and its Applications in Agriculture/Sericulture and in other F...
Bioinformatics and its Applications in Agriculture/Sericulture and in other F...Bioinformatics and its Applications in Agriculture/Sericulture and in other F...
Bioinformatics and its Applications in Agriculture/Sericulture and in other F...mohd younus wani
 
ANTI HIV USING NANOTECHNOLOGY
ANTI HIV USING NANOTECHNOLOGYANTI HIV USING NANOTECHNOLOGY
ANTI HIV USING NANOTECHNOLOGYChandanaSp
 
Evidencias2006ii 100619025253-phpapp01
Evidencias2006ii 100619025253-phpapp01Evidencias2006ii 100619025253-phpapp01
Evidencias2006ii 100619025253-phpapp01UNICA-Publicidad
 
Evidencias2006 ii
Evidencias2006 iiEvidencias2006 ii
Evidencias2006 iiHOME
 
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...iosrjce
 

Similar to Final Presentation (20)

Top 15 Biopharma Research Trends to Watch in 2023.pdf
Top 15 Biopharma Research Trends to Watch in 2023.pdfTop 15 Biopharma Research Trends to Watch in 2023.pdf
Top 15 Biopharma Research Trends to Watch in 2023.pdf
 
Environmental Transmission of Antimicrobial Resistance
Environmental Transmission of Antimicrobial ResistanceEnvironmental Transmission of Antimicrobial Resistance
Environmental Transmission of Antimicrobial Resistance
 
DNA Vaccines
DNA VaccinesDNA Vaccines
DNA Vaccines
 
antibiotics
antibioticsantibiotics
antibiotics
 
The Significance of Lifescience- An In-depth Exploration.pdf
The Significance of Lifescience- An In-depth Exploration.pdfThe Significance of Lifescience- An In-depth Exploration.pdf
The Significance of Lifescience- An In-depth Exploration.pdf
 
AMR & Alternative Stratergies - Microbiology
AMR & Alternative Stratergies - MicrobiologyAMR & Alternative Stratergies - Microbiology
AMR & Alternative Stratergies - Microbiology
 
2.3 marie-cécile ploy
2.3 marie-cécile ploy2.3 marie-cécile ploy
2.3 marie-cécile ploy
 
Science Magazine_Moderna_2017
Science Magazine_Moderna_2017Science Magazine_Moderna_2017
Science Magazine_Moderna_2017
 
mRNA vaccines against emerging infectious diseases; A challenging approach of...
mRNA vaccines against emerging infectious diseases; A challenging approach of...mRNA vaccines against emerging infectious diseases; A challenging approach of...
mRNA vaccines against emerging infectious diseases; A challenging approach of...
 
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...
 
broad spectrum antibiotics - Dr Sanjana Ravindra
broad spectrum antibiotics - Dr Sanjana Ravindrabroad spectrum antibiotics - Dr Sanjana Ravindra
broad spectrum antibiotics - Dr Sanjana Ravindra
 
Bioinformatics and its Applications in Agriculture/Sericulture and in other F...
Bioinformatics and its Applications in Agriculture/Sericulture and in other F...Bioinformatics and its Applications in Agriculture/Sericulture and in other F...
Bioinformatics and its Applications in Agriculture/Sericulture and in other F...
 
ANTI HIV USING NANOTECHNOLOGY
ANTI HIV USING NANOTECHNOLOGYANTI HIV USING NANOTECHNOLOGY
ANTI HIV USING NANOTECHNOLOGY
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
PIIS0966842X20301621.pdf
PIIS0966842X20301621.pdfPIIS0966842X20301621.pdf
PIIS0966842X20301621.pdf
 
Evidencias2006ii 100619025253-phpapp01
Evidencias2006ii 100619025253-phpapp01Evidencias2006ii 100619025253-phpapp01
Evidencias2006ii 100619025253-phpapp01
 
Cr ps awards_2019
Cr ps awards_2019Cr ps awards_2019
Cr ps awards_2019
 
Evidencias2006 ii
Evidencias2006 iiEvidencias2006 ii
Evidencias2006 ii
 
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
 
Rloia Pickettiir
Rloia PickettiirRloia Pickettiir
Rloia Pickettiir
 

Final Presentation

  • 1. Under the Guidance of: Er. Brajendra Shukla Coordinator, Biotechnology Engineering I.E.T., Bundelkhand University, Jhansi Dr. Anand Kr. Pandey Lecturer (Biotechnology Engineering) I.E.T., Bundelkhand University, Jhansi Presented By: Archana Kushwaha B.Tech (Biotechnology) 2nd Year Rafat Sabir B.Tech (Biotechnology) 2nd Year Swati Tripathi B.Tech (Biotechnology) 1st Year
  • 2.  A PATHOGENIC MICROORGANISM AND ESPECIALLY A BACTERIUM THAT HAS DEVELOPED RESISTANCE TO THE MEDICATIONS NORMALLY USED AGAINST IT.  IF A BACTERIUM CARRIES SEVERAL ANTIBIOTIC RESISTANCE GENES IT IS CALLED MULTIRESISTANT OR INFORMALLY A SUPERBUG OR SUPER BACTERIA.  THE BRANCH OF SCIENCE WHICH DEALS WITH THE STUDY OF SUPERBUGS IS CALLED METAGENOMICS.
  • 3. 1. Uncontrolled, improper and indiscriminate use of antibiotics for therapy and prophylaxis. 2. Inadequate lengths of therapy. 3. Unnecessary use, lack of activity, insufficient doses. 4. Poor hand hygiene & failure of infection control measures. 5. Pollution from nanomaterial, heavy metal, sewage sludge, animal slurry, disinfectants and fabric softeners.
  • 4.
  • 5. 0 2 4 6 8 10 12 14 16 18Numberofagentsapproved 0 1983-87 1988-92 1993-97 1998-02 2003-05 2008 Resistance •Infectious Diseases Society of America. Bad Bugs, No Drugs. July 2004; Spellberg B et al. Clin Infect Dis. 2004;38:1279-1286; •New antimicrobial agents. Antimicrob Agents Chemother. 2006;50:1912 Bars represent number of new antimicrobial agents approved by the FDA during that period
  • 6. Mechanism of Antibiotic Resistance  Drug inactivation or modification.  Alteration of target site.  Reduced drug accumulation.  Horizontal gene transfer and unlinked point mutations in the pathogen genome.  Innate genetic mutation.
  • 7.  Accepting resistance genes from other bacteria.  Conjugation, Transformation and Transduction.  Introduced artificially into a microorganism through laboratory protocols, sometimes used as a  By enzyme inactivation.
  • 8. Infectious Disease Society of America Examples of SUPERBUGS: 1. MRSA (Methicillin Resistant Staphylococcus aureus) 2. H1N1 (Hemagglutinin Type 1 and Neuraminidase Type 1) 3. NDM-1 (New Delhi Metallo β Lactamase-1) 4. VRSA (Vancomycin Resistant Staphylococcus aureus) 5. ESBL (Extended Spectrum Beta-Lactamase) 6. VRE (Vancomycin Resistant Enterococcus) 7. MRAB (Multidrug Resistant Actinomucor baumannii ). FEWBAD BUGS, FEW DRUGS
  • 9.  Resistant against antibiotic Methicillin.  Found on the mucous membranes and the human skin. This is one virus that does not need open wound to enter just contact with your skin.  It was one of the earlier bacteria in which penicillin resistance was 1. MRSA: Methicillin Resistant Staphylococcus aureus MRSA
  • 10. 2. H1N1 Flu Virus (Swine Flu)  H1N1 virus responsible for today’s biggest threat i.e. Swine Flu is also becoming antiviral resistant.  A class of antivirals, ‘neuraminidase inhibitors (NAIs)’ is effective against all human influenza viruses. e.g. oseltamivir & zanamivir.  Doctors generally prescribes these antivirals against swine flu.  Studies done by MEDLINE & EMBASE revealed a pooled incidence rate for oseltamivir resistance of 2.6% as a result of oseltamivir use.
  • 11. MORBIDITY AND MORTALITY CDC estimates that the number of MRSA has doubled nationwide 1999 approx. 127,000 up to 2005 approx. 278,000. At the same time the amount of deaths increased from 11,000 to more than 17,000. Incidence increase in β-Lactamase from 17% to 23% between 1991 and 2001 in UK. 44 isolates with NDM-1 in Chennai, 26 in Haryana, 37 in the UK, and 73 in other sites in India and Pakistan.
  • 12. Death attributable to AMR (Anti Microbial Resistance) every year compared to other causes of death. Source: Wikipedia by Jim O'Neill Chairman of the Review on Antimicrobial Resistance
  • 13.  Selecting the most appropriate antibiotic based on the patient, risk factors, suspected infection and resistance.  Administering antibiotics at the right dose, duration & take them only if necessary.  Completing the full prescription given by doctor, even if you feel better.  Changing antibiotic dosage or therapy based on resistance.  Replace conventional antibiotics to peptide antibiotics.
  • 14. WASH YOUR HANDS!!! And maintain a hygienic surrounding. BSI gloves, mask with face shield, gown-Not a bad idea. Disinfect you and your equipment including your truck. Be environment friendly and say ‘NO’ to pollution.
  • 15. NANOTECHNOLOGY BOOST WAR ON SUPERBUGS  Scientists from the London Centre for Nanotechnology (LCN) are using a novel nanomechanical approach to investigate the workings of vancomycin.  Cantilever Array coated with mucopeptide – Leads to the development of more powerful and effective antibiotics in future.  Engineers design nanoparticles that deliver high doses of antibiotics directly to bacteria. Cantilever Array Nanoparticles(green) targeting Bacteria(red)
  • 16. 1. Gene-editing Systems (i). CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)  MIT engineers have developed a gene-editing system-CRISPR that can kill superbug.  It involves a set of proteins , used by bacteria against bacteriophages. One of these proteins is Cas9, a DNA cutting enzyme.  RNA guide strands of bacteria are used to target genes for antibiotic resistance like NDM-1 & SVH-18.  Studies have done on waxworm & mice. Biotechnological Approach in Prevention of ‘SUPERBUGS’
  • 17. (ii) TALENs (Transcription Activator Like Effector Nucleases)  TALEs are naturally occurring protein from the pathogen Xanthomonas containing DNA binding domains.  Can be used to edit genomes using double strand breaks & it cleaves at desired site.  Use to generate mutant alleles of 15 genes in cultured somatic cells or human pluripotent stem cells.  Use to generate stably modified human embryonic stem cell & induced pluripotent stem cells (IPSCs) to generate knockout mice, knockout zebrafish.  Utilized experimentally to correct genetic errors underlying diseases.
  • 18.
  • 19. 2. Combi-GEM (Combinatorial Genetics En Masse)  Enables the rapid generation of high-order barcoded combinations of genetic elements.  Researchers created a library of 34,000 pairs of bacterial genes which code for transcription factor.  These genes are then transmitted into superbugs & treated them with different antibiotic.  Illumina sequencing reveals those gene pairs that potentiated the killing of bacteria by manifolds.  Once the mechanism is investigated, we can design more effective antibiotics.
  • 20. 3. Engineered Viruses (Bacteriophages)  Researchers have engineered a virus that eliminates bacterial defense system and hence increase the effectiveness of antibiotics.  These viruses attack the SOS system of bacteria- A DNA repair system that comes into action when bacteria is exposed to antibiotics.  Used in conjunction with traditional antibiotics (Quonolones, β-lactams).
  • 21. 4. Beneficial Insects Scientists also hypothesised that locust brain juice could cut MRSA in humans because it contains substances that kill bacteria. Honey is also studied as a weapon against superbug.
  • 22. 5. Computer Aided Drug Designing (CAD)  Virtual screening of billions of compounds.  Availability of chemical databases & their online distribution is useful in drug designing.  Many softwares are available for screening the lead like compound from chemical databases.  X-Ray, NMR and Docking are milestones in structure based drug designing.  Are cost-effective, reliable and time-saving.
  • 23. 6. FIRST WEAPON AGAINST MRSA  The drug, Staphefekt, is reported as the first weapon against MRSA infection.  It combines two bits of a enzyme- ‘Endolysin’, found in viruses.  It latches on to bacterium’s outer skin part.  It specifically kill Staphylococcus and doesn’t harm other bacteria. MRSA
  • 24.  Research is being done to find treatment.  A newly discovered antibiotic, called ‘Teixobactin’, kills a wide range of superbugs.  “eCAPs” (engineered Cationic Antimicrobial Peptides) are being synthesised.  Newer Antibiotics in pipeline:- Dalbavancin, Oritavancin, Telavancin, Ceftobiprole (Zeftera®), Ceftaroline, Faropenem. eCAPs
  • 25. References:  Textbook on Microbiology by Michael J.Paleczar, JR., E.C.S.Chan, Noel R.Kreig.  Textbook on Biochemistry by Lehninger.  en.wikipedia.org  www.nanowork.com  www.sciencedaily.com  www.latimes.com  www.pubmed.com  www.nature.com
  • 26.